Nav Close

UNOMR, a TechBio startup from ETH Zurich, is pioneering single-molecule protein modification analysis through their innovative serial nanopore sensor, currently focusing on protein glycosylation. Addressing a US$ 60B market, their patented solution has far-reaching applications across healthcare, pharmaceutical development, and food science, offering unprecedented insights into proteins for therapeutic discovery and medical food innovation. Driven by the vision of bringing advanced proteomics directly to the patient, UNOMR aims to catalyze the next breakthrough in precision medicine by making sophisticated protein analysis accessible.